|
1.
|
|
21 p, 621.9 KB |
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
/
Godman, Brian (Universiti Sains Malaysia) ;
Haque, Mainul (Universiti Pertahanan Nasional Malaysia) ;
Leong, Trudy (South African National Department of Health) ;
Allocati, Eleonora (Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS) ;
Kumar, Santosh (Department of Periodontology and Implantology, Karnavati University) ;
Islam, Salequl (Department of Microbiology, Jahangirnagar University) ;
Charan, Jaykaran (Department of Pharmacology, All India Institute of Medical Sciences) ;
Akter, Farhana (Department of Endocrinology, Chittagong Medical College) ;
Kurdi, Amanj (Department of Pharmacology, Hawler Medical University) ;
Vassalo, Carlos (Facultad de Ciencias Médicas, Universidad Nacional del Litoral) ;
Bakar, Muhammed Abu (Department of Endocrinology and Metabolism, Chattogram Maa-O-Shishu Hospital Medical College) ;
Rahim, Sagir Abdur (Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders General Hospital) ;
Sultana, Nusrat (Department of Endocrinology and Metabolism, Bangabandhu Sheik Mujib Medical University Hospital) ;
Deeba, Farzana (Department of Obstetrics and Gynaecology, Bangabandhu Sheik Mujib Medical University) ;
Khan, M. A. Halim (Shaheed Suhrawardy Medical College Hospital) ;
Alam, A. B. M. Muksudul (Shaheed Suhrawardy Medical College Hospital) ;
Jahan, Iffat (Department of Physiology, Eastern Medical College (Bangladesh)) ;
Kamal, Zubair Mahmood (National Institute of Mental Health (Bangladesh)) ;
Hasin, Humaira (Epsom and St Helier University Hospitals NHS Trust) ;
Munzur-E-Murshid (Women's Integrated Sexual Health (WISH) 2 Access Choice Together Innovate Ownership Now (ACTION) Project, Handicap International (Bangladesh)) ;
Nahar, Shamsun (Department of Microbiology, Jahangirnagar University) ;
Haque, Monami (Human Resource Department Rupayan Center) ;
Dutta, Siddhartha (Department of Pharmacology, All India Institute of Medical Sciences) ;
Abhayanand, Jha Pallavi (Department of Pharmacology, All India Institute of Medical Sciences) ;
Kaur, Rimple Jeet (Department of Pharmacology, All India Institute of Medical Sciences) ;
Rwegerera, Godfrey Mutashambara (University of Botswana) ;
do Nascimento, Renata Cristina Rezende Macedo (Department of Pharmacy, Federal University of Ouro Preto) ;
Dias Godói, Isabella Piassi (Universidade Federal do Sul e Sudeste do Pará) ;
Irfan, Mohammed (Faculdade de Odontologia, Universidade Federal de Pelotas) ;
Amu, Adefolarin A. (Pharmacy Department, Eswatini Medical Christian University) ;
Matowa, Patrick (Pharmacy Department, Eswatini Medical Christian University) ;
Acolatse, Joseph (Cape Coast Teaching Hospital) ;
Incoom, Robert (Cape Coast Teaching Hospital) ;
Sefah, Israel Abebrese (Department of Pharmacy Practise University of Health and Allied Sciences) ;
Acharya, Jitendra (Department of Dentistry, SP Medical College) ;
Opanga, Sylvia (Department of Pharmaceutics and Pharmacy Practise, University of Nairobi) ;
Njeri, Lisper Wangeci (Department of Pharmacy, Kenyatta National Hospital) ;
Kimonge, David (Department of Pharmaceutics and Pharmacy Practise, University of Nairobi) ;
Kwon, Hye-Young (Mokwon University) ;
Bae, SeungJin (Ewha Woman's University) ;
Khuan, Karen Koh Pek (Friends'Pharmacy Pekan Sg Besi 42G) ;
Abubakar, Abdullahi Rabiu (Department of Pharmacology and Therapeutics, Bayero University) ;
Sani, Ibrahim Haruna (Yusuf Maitama Sule University) ;
Khan, Tanveer Ahmed (National Institute of Health) ;
Hussain, Shahzad (National Institute of Health) ;
Saleem, Zikria (Department of Pharmacy Practise, The University of Lahore) ;
Malande, Oliver Ombeva (East Africa Centre for Vaccines and Immunisation) ;
Piloya-Were, Thereza (Makerere University) ;
Gambogi, Rosana (National Resources Fund) ;
Hernandez Ortiz, Carla (National Resources Fund) ;
Alutuli, Luke (University Teaching Hospital Group, Department of Pharmacy) ;
Kalungia, Aubrey Chichonyi (Department of Pharmacy, University of Zambia) ;
Hoxha, Iris (Department of Pharmacy, University of Medicine) ;
Marković-Peković, Vanda (Department of Social Pharmacy, University of Banja Luka) ;
Tubic, Biljana (Department of Medicinal Chemistry, University of Banja Luka) ;
Petrova, Guenka (Medical University of Sofia (Sofia, Bulgària)) ;
Tachkov, Konstantin (Medical University of Sofia (Sofia, Bulgària)) ;
Laius, Ott (State Agency of Medicines) ;
Harsanyi, András (Department of Health Policy and Health Economics, Eotvos Lorand University) ;
Inotai, András (Center of Health Technology Assessment, Semmelweis University) ;
Jakupi, Arianit (UBT Higher Education Institute) ;
Henkuzens, Svens ;
Garuoliene, Kristina (Vilnius University (Vilnius, Lituània)) ;
Gulbinovič, Jolanta (Vilnius University (Vilnius, Lituània)) ;
Wladysiuk, Magdalena (HTA Consulting) ;
Rutkowski, Jakub (HTA Consulting) ;
Mardare, Ileana (Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest) ;
Fürst, Jurij (Health Insurance Institute) ;
McTaggart, Stuart (Public Health Scotland) ;
MacBride-Stewart, Sean (Pharmacy Services, Greater Glasgow and Clyde) ;
Pontes García, Caridad (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Zara, Corinne (Servei Català de la Salut) ;
Tagoe, Eunice Twumwaa (Department of Management Science, University of Strathclyde) ;
Banzi, Rita (Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS) ;
Wale, Janney (Independent Consumer Advocate) ;
Jakovljevic, Mihajlo (Hosei University Tokyo)
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. [...]
2021 -  10.3389/fpubh.2021.671961
Frontiers in Public Health, Vol. 9 (june 2021)
|
|
|
2.
|
|
11 p, 1.1 MB |
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs
/
Godman, Brian (University of Strathclyde) ;
Malmström, Rickard E. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Diogène Fadini, Eduard (Hospital Universitari Vall d'Hebron) ;
Jayathissa, Sisira (Hutt Valley DHB. Department of Medicine) ;
McTaggart, Stuart (NHS National Services Scotland) ;
Cars, Thomas (Uppsala University. Department of Medical Sciences) ;
Alvarez-Madrazo, Samantha (University of Strathclyde) ;
Baumgärtel, Christoph (Austrian Medicines and Medical Devices Agency) ;
Brzezinska, Anna (Agency for Health Technology Assessment) ;
Bucsics, Anna (Hauptverband der Österreichischen Sozialversicherungsträger) ;
Campbell, Stephen (University of Manchester. Centre for Primary Care) ;
Eriksson, Irene (Stockholm County Council. Department of Healthcare Development) ;
Finlayson, Alexander (University of Oxford. Green Templeton College) ;
Fürst, Jurij (Health Insurance Institute) ;
Garuoliene, Kristina (National Health Insurance Fund) ;
Gutiérrez-Ibarluzea, Iñaki (Osasun Saila. Ezagutu Osteba arloa) ;
Hviding, Krystyna (Norwegian Medicines Agency) ;
Herholz, Harald (Kassenärztliche Vereinigung Hessen) ;
Joppi, Roberta (Azienda Sanitaria Locale of Verona. Pharmaceutical Drug Department) ;
Kalaba, Marija (Republic Institute for Health. Department of Medicines and Pharmacoeconomics) ;
Laius, Ott (State Agency of Medicines) ;
Malinowska, Kamila (National Health Fund. Drug Management Department) ;
Pedersen, Hanne B. (Division of Health Systems and Public Health, Health Technologies and Pharmaceuticals, WHO Regional Office for Europe) ;
Markovic-Pekovic, Vanda (Ministry of Health and Social Welfare) ;
Piessnegger, Jutta (Hauptverband der Österreichischen Sozialversicherungsträger) ;
Selke, Gisbert (Wissenschaftliches Institut der AOK (WidO)) ;
Sermet, Catherine (IRDES) ;
Spillane, Susan (Trinity College. Department of Pharmacology and Therapeutics) ;
Tomek, Dominik (Slovak Medical University. Faculty of Pharmacy) ;
Vončina, Luka (Ministry of Health) ;
Vlahović-Palčevski, Vera (University Hospital Rijeka. Unit for Clinical Pharmacology) ;
Wale, Janet (Independent Consumer Advocate, VIC) ;
Wladysiuk, Magdalena (HTA Consulting) ;
van Woerkom, Menno (Dutch Institute for Rational Use of Medicine) ;
Zara, Corinne (Institut Català de la Salut) ;
Gustafsson, Lars L. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Universitat Autònoma de Barcelona
Background : There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with non-valvular atrial fibrillation (AF), exemplifies this issue. [...]
2014 - 10.3389/fphar.2014.00109
Frontiers in Pharmacology, Vol. 5 (june 2014)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
